Investigators from 15 institutions in the United States, Europe, and Israel are collaborating on the largest study to date on gliomas. The goal is to recruit 6,000 glioma patients and 6,000 healthy controls to learn more about the genetic and environmental risk factors in brain tumor development.
Brain Tumor Family Study (Gliogene)
Families eligible for participation in the Gliogene study must have two biologically related family members who have been diagnosed with a primary brain tumor known as a glioma.
If you decide to participate in this study, we'll ask you to take part in a 45 minute research interview and risk questionnaire over the phone or in person. Most of the interview questions address your family's medical history. Additionally, we may ask you and some of your family members to give a small blood sample to help us identify possible genes related to development of brain tumors.
All participation can be completed by phone or mail. We will also ask permission to access the medical records of family members with brain tumors. There is no cost to participate. Register for this study.
International Brain Tumor Study (Glioma Case-Control Study)
Newly diagnosed glioma patients between the ages of 18-80, and who are patients at one the 15 collaborating institutions are eligible to participate in the international brain tumor study/glioma case-control study.
If you are located in the United States: Newly diagnosed glioma patients attending any of the collaborating institutions in the United States will be introduced to the study through a researcher during an appointment.
If you are located in Europe and Israel: All newly diagnosed glioma patients between the ages of 18-80 are eligible to participate in the international brain tumor study.
If you decide to participate in this study, we will ask you to complete a questionnaire over the phone or in person. The questionnaire includes questions about your medical history, family history of cancers, environmental exposures and day-to-day lifestyle factors. You will also be asked to provide a blood or saliva sample. There is no cost to participate in this study.